Brief: Aileron Therapeutics Inc Says Cash Runway Has Been Extended
Aug 1 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS INC- CASH RUNWAY HAS BEEN EXTENDED;
NOW
EXPECTED TO FUND OPERATIONS THROUGH END OF 1Q 2024
Source text for Eikon: ID:nGNXN9VYq
Further company coverage: ALRN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering